Edward Mitre is an Infectious Disease physician affiliated with Uniformed Services University of the Health Sciences. OpenAlex indexes 139 publications with 2,800 citations (h-index 32); ClinicalTrials.gov lists 1 registered study matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
8901 Wisconsin Ave
Bethesda, MD 208893357
Telephone
301-295-6400Provider last certified this registry record 10 Jul 2024.
Clinical trials
- Comparative Immunogenicity of Respiratory Virus Vaccines (CIRV2) Study
Sponsor: Henry M. Jackson Foundation for the Advancement of Military Medicine
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
NIH funding
3 NIH research awards on record, funded 2006–2010 per NIH RePORTER. The latest:
- Role of basophils and IgE in the immune response to Litomosoides
Henry M. Jackson Fdn for the Adv Mil/med
FY2010$382,500R01AI076522 - Role of basophils and IgE in the immune response to Litomosoides
Henry M. Jackson Fdn for the Adv Mil/med
FY2009$382,500R01AI076522 - Protection against Type I diabetes by parasitic helminths
Henry M. Jackson Fdn for the Adv Mil/med
FY2008$2,281,500DP2DK083131
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Natural killer cells and BNT162b2 mRNA vaccine reactogenicity and durability
Frontiers in Immunology
2023 - SARS-CoV-2 BA.1 variant is neutralized by vaccine booster–elicited serum but evades most convalescent serum and therapeutic antibodies
Science Translational Medicine
2022
Similar KOLs
Other experts from the same institution or the same specialty.
Thomas Darling, MD, PhD
Uniformed Services University of the Health Sciences
Jeremy Perkins, MD
Uniformed Services University of the Health Sciences
Francis G. O’Connor
Uniformed Services University of the Health Sciences
Leonard Sperling, MD
Uniformed Services University of the Health Sciences
Thomas Walsh, MD
Cornell University
Douglas Richman, MD
University of California San Diego
Vance Fowler, MD
Duke University
Myron Cohen, MD
University of North Carolina at Chapel Hill School of Medicine
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”